Sven Wehrwein
Director at AtriCure, Inc. (ATRC); Director at Proto Labs Inc (PRLB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 30SEC | ATRCAtriCure, Inc. | Sell | 25,00040,518 held (−38%) | $37.84 | $946K | +47.5% |
| Jun 4SEC | PRLBProto Labs Inc | Sell | 1,50033,005 held (−4%) | $76.91 | $115K | +22.0% |
| Jun 4SEC | PRLBProto Labs Inc | Sell | 50032,505 held (−2%) | $78.38 | $39K | +19.7% |
| Nov 26SEC | ATRCAtriCure, Inc. | Sell | 5,03334,374 held (−13%) | $37.32 | $188K | +49.5% |
| Nov 26SEC | ATRCAtriCure, Inc. | Sell | 4,96734,374 held (−13%) | $38.00 | $189K | +46.9% |
- Sell
Director Sven Wehrwein sold $946K of ATRC at $37.84 — cuts the stake by 38%.